medigraphic.com
ISSN 1561-2929 (Print)

2017, Number 1

<< Back Next >>

RCAN 2017; 27 (1)

Anthropometry in the recognition of cardiovascular risk

de León MDL, Muñoz MMG, Ochoa C

Language: Spanish
References: 162
Page: 167-188
PDF size: 361.35 Kb.


ABSTRACT

Cardiovascular disease (CVD) ranks first in the health picture of almost all the countries of the world, notwithstanding the socioeconomical status of the societies. Strategies required for identification and realization of the cardiovascular risk (CVR) are thus needed and justified. Influence of body fat, and visceral fat as a topographical specialization, upon the onset and progression of CVD has been established. CVR might be estimated by means of global as well as regional markers of obesity. Hence, anthropometry might serve for estimating the size of body fat, and so, to quantitate CVR in a subject presenting with excessive body weight. Anthropometry might also serve for measuring the impact of food and nutritional interventions in the reduction of CVR. It is expected assimilation of anthropometric protocols for assessing body fat in medical care settings might contribute to a better appreciation of the CVR, and so, to improved treatment strategies of CVD.


REFERENCES

  1. Laslett LJ, Alagona P, Clark BA, Drozda JP, Saldivar F, Wilson SR; et al. The worldwide environment of cardiovascular disease: Prevalence, diagnosis, therapy, and policy issues: A report from the American College of Cardiology. J Am Coll Cardiol 2012; 60(25 Suppl):S1-S49.

  2. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M; et al. Heart disease and stroke statistics- 2016 update. Circulation 2016;133(4):e38- e360. Disponible en: http://circ.ahajournals.org/content/133/4/ e38.short. Fecha de última visita: 23 de Febrero del 2016.

  3. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 2002;88:119-24.

  4. Levi F, Chatenoud L, Bertuccio P, Lucchini F, Negri E, La Vecchia C. Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: An update. Eur J Cardiov Prev Rehab 2009;16:333-50.

  5. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97:596-601.

  6. Schargrodsky H, Hernández Hernández R, Champagne BM, Silva H, Vinueza R, Ayçaguer LCS; et al. CARMELA: Assessment of cardiovascular risk in seven Latin American cities. Am J Med 2008;121:58-65.

  7. Lavados PM, Hennis AJ, Fernandes JG, Medina MT, Legetic B, Hoppe A; et al. Stroke epidemiology, prevention, and management strategies at a regional level: Latin America and the Caribbean. The Lancet Neurology 2007;6:362-72.

  8. Rosas Peralta M, Attie F. Enfermedad cardiovascular: Primera causa de muerte en adultos de México y el mundo. Archivos Cardiología México 2007; 77:91-3.

  9. Velázquez Monroy O, Barinagarrementería Aldatz FS, Rubio Guerra AF, Verdejo J, Méndez Bello MA, Violante R; et al. Morbilidad y mortalidad de la enfermedad isquémica del corazón y cerebrovascular en México. 2005. Archivos Cardiología México 2007;77:31-9.

  10. Córdova Villalobos JÁ, Barriguete Meléndez JA, Lara Esqueda A, Barquera S, Rosas Peralta M, Hernández Ávila M; et al. Las enfermedades crónicas no transmisibles en México: Sinopsis epidemiológica y prevención integral. Salud Pública México 2008;50:419-27.

  11. Chávez Domínguez R, Ramírez Hernández JA, Casanova Garcés JM. La cardiopatía coronaria en México y su importancia clínica, epidemiológica y preventiva. Archivos Cardiología México 2003;73:105-14.

  12. Ezzati M, López AD, Rodgers A, Vander Hoorn S, Murray CJ; for the Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. The Lancet 2002;360(9343): 1347-60.

  13. Lynch JW, Kaplan GA, Cohen RD, Tuomilehto J, Salonen JT. Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol 1996;144:934-42.

  14. Royo Bordonada MA, Lobos JM, Brotons C, Villar F, de Pablo C, Armario P; et al. El estado de la prevención cardiovascular en España. Medicina Clínica [Barcelona] 2014;142:7-14.

  15. Vega Abascal J, Guimará Mosqueda M, Vega Abascal L. Riesgo cardiovascular, una herramienta útil para la prevención de las enfermedades cardiovasculares. Rev Cubana Med Gen Int 2011;27:91-7.

  16. Baena Díez JM, Félix FJ, Grau M, de León AC, Sanz H, Leal M; et al. Tratamiento y control de los factores de riesgo según el riesgo coronario en la población española del estudio DARIOS. Rev Esp Cardiol 2011;64:766-73.

  17. Lozano R, Gómez Dantés H, Garrido Latorre F, Jiménez Corona A, Campuzano Rincón JC, Franco Marina F; et al. La carga de enfermedad, lesiones, factores de riesgo y desafíos para el sistema de salud en México. Salud Pública México 2013;55:580-94.

  18. Murray CJ, Ezzati M, López AD, Rodgers A, Vander Hoorn S. Comparative quantification of health risks: Conceptual framework and methodological issues. Population Health Metrics 2003;1(1):0-0. Disponible en: https://pophealthmetrics.biomedcentral.c om/articles/10.1186/1478-7954-1-1. Fecha de última visita: 13 de Septiembre del 2016.

  19. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F; et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. The Lancet 2004; 364(9438):937-52.

  20. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 2005;26:1765-73.

  21. Terrados N, Valcárcel G, Venta R. Los nuevos factores de riesgo cardiovascular y la actividad física. Apunts Medicina de l" Esport [Barcelona] 2010;45:201-8.

  22. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins AI and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005;294:326-33.

  23. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004;291: 335-42.

  24. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. The Lancet 2008;371 (9623):1513-8.

  25. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006;444 (7121);875-82.

  26. Weber C, Noels H. Atherosclerosis: Current pathogenesis and therapeutic options. Nature Medicine 2011;17: 1410-22.

  27. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473(7347):317-24.

  28. DeFronzo RA. The Claude Bernard Lecture 2009: Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: The missing links. Diabetologia 2010;53:1270-87.

  29. DeFronzo RA, Ferrannini E. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.

  30. Weinsier RL, Nelson KM, Hensrud DD, Darnell BE, Hunter GR, Schutz Y. Metabolic predictors of obesity. Contribution of resting energy expenditure, thermic effect of food, and fuel utilization to four-year weight gain of post-obese and never-obese women. J Clin Invest 1995;95:980-5.

  31. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004;89: 2595-2600.

  32. Tilg H, Moschen AR. Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nature Rev Immunol 2006;6:772-83.

  33. Santana Porbén S. Las adipocitoquinas en la génesis y evolución del síndrome metabólico. RCAN Rev Cubana Aliment Nutr 2010;20:304-17.

  34. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterol 2007;132: 2169-80.

  35. Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nature Rev Cardiol 2009;6:399-409.

  36. Friedman JM. Obesity: Causes and control of excess body fat. Nature 2009;459(7245):340-2.

  37. Haffner SM, Valdez RA, Stern MP, Katz MS. Obesity, body fat distribution and sex hormones in men. Int J Obes Rel Metab Dis 1993;17:643-9.

  38. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: An approach for developing guidelines based on body mass index. Am J Clin Nutr 2000;72:694-701.

  39. Shimokata H, Tobin JD, Muller DC, Elahi D, Coon PJ, Andres R. Studies in the distribution of body fat: I. Effects of age, sex, and obesity. J Gerontol 1989; 44(2 Suppl):M66-M73.

  40. Wronska A, Kmiec Z. Structural and biochemical characteristics of various white adipose tissue depots [Review]. Acta Physiologica 2012;205:194-208.

  41. Ibrahim MM. Subcutaneous and visceral adipose tissue: Structural and functional differences. Obes Rev 2010;11:11-8.

  42. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995;95:2409-15.

  43. Luna Luna M, Medina Urrutia A, Vargas Alarcón G, Coss Rovirosa F, Vargas Barrón J, Pérez Méndez Ó. Adipose tissue in metabolic syndrome: Onset and progression of atherosclerosis. Arch Med Res 2015;46:392-407.

  44. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss. Circulation 2006;113: 898-918.

  45. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: A randomized trial. JAMA 2003;289: 1799-1804.

  46. Lee SY, Gallagher D. Assessment methods in human body composition. Cur Op Clin Nutr Metab Care 2008;11: 566-72.

  47. Goldman RF, Buskirk ER. Body volume measurement by underwater weighing: Description of a method. Techn Meas Body Comp 1961;3:78-89.

  48. Katch F, Michael ED, Horvath SM. Estimation of body volume by underwater weighing: Description of a simple method. J Appl Physiol 1967;23: 811-3.

  49. Dewit O, Fuller NJ, Fewtrell MS, Elia M, Wells JCK. Whole body air displacement plethysmography compared with hydrodensitometry for body composition analysis. Arch Dis Child 2000;82:159-64.

  50. Sjostrom L, Kvist H, Cederblad A, Tylen U. Determination of total adipose tissue and body fat in women by computed tomography, 40K, and tritium. Am J Physiol- Endocrinol Metab 1986;250: E736-E745.

  51. Kvist H, Sjöström L, Chowdhury B, Alpsten M, Arvidsson B, Larsson L, Cederblad Å. Body fat and adipose tissue determinations by computed tomography and by measurements of total body potassium. En: In vivo body composition studies. Springer US. New York: 1990. pp. 197-218.

  52. Vehrs PR, Parker DL, Fellingham GW, Adams TD, Robison RO, Fisher AG. Magnetic resonance imaging of total body fat in young adult men. Res Sports Med 1995;6:71-9.

  53. van der Ploeg GE, Withers RT, Laforgia J. Percent body fat via DEXA: Comparison with a four-compartment model. J Appl Physiol 2003;94:499-506.

  54. Johansson AG, Forslund A, Sjödin A, Mallmin H, Hambraeus L, Ljunghall S. Determination of body composition- A comparison of dual-energy X-ray absorptiometry and hydrodensitometry. Am J Clin Nutr 1993;57:323-6.

  55. Ferland M, Després JP, Tremblay A, Pinault S, Nadeau A, Moorjani S; et al. Assessment of adipose tissue distribution by computed axial tomography in obese women: Association with body density and anthropometric measurements. Brit J Nutr 1989;61:139-48.

  56. Yoshizumi T, Nakamura T, Yamane M, Waliul Islam AHM, Menju M, Yamasaki K; et al. Abdominal fat: Standardized technique for measurement at CT. Radiology 1999;211:283-6.

  57. Staten MA, Totty WG, Kohrt WM. Measurement of fat distribution by magnetic resonance imaging. Inv Radiol 1989;24:345-49.

  58. Seidell JC, Bakker CJ, van der Kooy K. Imaging techniques for measuring adipose-tissue distribution- A comparison between computed tomography and 1.5-T magnetic resonance. Am J Clin Nutr 1990;51: 953-7.

  59. Lukaski HC, Bolonchuk WW, Hall CB, Siders WA. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 1986;60:1327-32.

  60. Van der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: A practical guide. Int J Obes 1993;17: 187-97.

  61. Wang J, Thornton JC, Kolesnik S, Pierson RN. Anthropometry in body composition: An overview. Ann NY Acad Sci 2000;904:317-26.

  62. Norton K, Whittingham N, Carter L, Kerr D, Gore C, Marfell-Jones M. Measurement techniques in anthropometry. Anthropometrica 1996;1: 25-75.

  63. Quetelet A. Recherches sur le poids de l`homme aux different âges. Nouveaux memoire de l’Academie Royale des Sciences et Belles-Lettres de Bruxelles. Bruselas: 1832.

  64. Quetelet A. A treatise on man and the development of his faculties. Paris: 1842 [Originally published in French]. Reimpreso en: Burt Franklin Publishing House. New York: 1968.

  65. Garrow JS, Webster J. Quetelet´s index (W/H2) as a measure of fatness. Int J Obes 1985;9:147-53.

  66. Bosy-Westphal A, Geisler C, Onur S, Korth O, Selberg O, Schrezenmeir J, Müller MJ. Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obes 2006;30:475-82.

  67. Deurenberg P, Ge K, Gaj Hautvast J, Jingzhong W. Body mass index as predictor for body fat: Comparison between Chinese and Dutch adult subjects. Asia Pac J Clin Nutr 1997;6: 102-5.

  68. Waterlow JC. Classification and definition of protein-calorie malnutrition. Brit Med J 1972; 3(5826):566-9.

  69. James WPT, Ferro-Luzzi A, Waterlow JC. Definition of chronic energy deficiency in adults. Report of a working party of the International Dietary Energy Consultative Group. Eur J Clin Nutr 1988;42:969-81.

  70. Norma Oficial Mexicana NOM-008- SSA3-2010. Para el tratamiento integral del sobrepeso y la obesidad. Ciudad México: 2010. Diario Oficial de la Federación. Disponible en: http://www.dof.gob.mx/nota_detalle.php ?codigo=5154226. Fecha de última visita: 13 de Octubre del 2016.

  71. Barrera Cruz A, Rodríguez González A, Molina Ayala MA. Escenario actual de la obesidad en México. Rev Med Inst Mex Seguro Soc 2013;51:292-9.

  72. Barquera S, Campos Nonato I, Hernández Barrera L, Pedroza A, Rivera Dommarco JA. Prevalence of obesity in Mexican adults 2000-2012. Salud Pública México 2013;55(Supl):S151- S160.

  73. Dudina A, Cooney MT, Bacquer DD, Backer GD, Ducimetière P; et al; for the SCORE investigators. Relationships between body mass index, cardiovascular mortality, and risk factors: A report from the SCORE investigators. Eur J Cardiovasc Prev Rehabil 2011;18(5):731-42.

  74. Romero Corral A, Somers VK, Sierra Johnson J, Thomas RJ, Bailey KR, Collazo Clavell ML; et al. Accuracy of body mass index to diagnose obesity in the US adult population. Int J Obes 2008; 32:959-66.

  75. Flegal KM, Ki BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: A systematic review and meta-analysis. JAMA 2013;309:71-82.

  76. González Villalpando C. La obesidad como factor de riesgo cardiovascular en México: Estudio en población abierta. Rev Invest Clín [México] 1993;45: 13-21.

  77. Arjona Villicaña RD, Herrera Sánchez LF, Sumárraga Ugalde CDM, Alcocer Gamboa MA. Asociación entre el índice de masa corporal y el perfil de lípidos en niños y adolescentes mexicanos con obesidad: Un análisis retrospectivo. Bol Méd Hosp Inf Méx 2014;71:88-94.

  78. Brown JD, Buscemi J, Milsom V, Malcolm R, O’Neil PM. Effects on cardiovascular risk factors of weight losses limited to 5-10%. Trans Behav Med 2016;6:339-46.

  79. Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG; et al.; for the Look AHEAD Research Group. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 2011; 34:1481-6.

  80. Blackburn G. Effect of degree of weight loss on health benefits. Obes Res 1995; 3(Suppl):S211-S216.

  81. Zamboni M, Armellini F, Harris T, Turcato E, Micciolo R, Bergamo Andreis IA, Bosello O. Effects of age on body fat distribution and cardiovascular risk factors in women. Am J Clin Nutr 1997;66:111-5.

  82. Rimm EB, Stampfer MJ, Giovannucci E, Ascherio A, Spiegelman D, Colditz GA, Willett WC. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 1995; 141:1117-27.

  83. Wu CY, Chou YC, Huang N, Chou YJ, Hu HY, Li CP. Association of body mass index with all-cause and cardiovascular disease mortality in the elderly. PLoS One 2014;9(7):e102589. Disponible en: http://journals.plos.org/plosone/article?id =10.1371/journal.pone.0102589. Fecha de última visita: 23 de Febrero del 2016.

  84. Prentice AM, Jebb SA. Beyond body mass index. Obes Rev 2001;2:141-7.

  85. Lim GB. CVD risk and the “obesity paradox”. Nature Reviews Cardiology 2015;12:560. Disponible en: http://www.nature.com/nrcardio/journal/ v12/n10/full/nrcardio.2015.128.html. Fecha de última visita: 2 de Marzo del 2016.

  86. Eckel N, Meidtner K, Kalle-Uhlmann T, Stefan N, Schulze MB. Metabolically healthy obesity and cardiovascular events: A systematic review and metaanalysis. Eur J Prev Cardiol 2015;23: 956-66.

  87. Zamboni M, Turcato E, Armellini F, Kahn HS, Zivelonghi A, Santana H; et al. Sagittal abdominal diameter as a practical predictor of visceral fat. Int J Obes 1998;22:655-60.

  88. Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A; et al. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-8.

  89. Ebbert JO, Jensen MD. Fat depots, free fatty acids, and dyslipidemia. Nutrients 2013;5:498-508.

  90. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: Evidence in support of current National Institutes of Health guidelines. Arch Int Med 2002;162: 2074-9.

  91. Tchernof A, Després JP. Pathophysiology of human visceral obesity: An update. Physiol Rev 2013;93: 359-404.

  92. Misra A, Wasir JS, Vikram NK. Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups. Nutrition 2005;21:969-76.

  93. Fernández JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European- American, and Mexican-American children and adolescents. J Pediatr 2004;145:439-44.

  94. Pérez León S, Díaz-Perera Fernández, G. Circunferencia de la cintura en adultos, indicador de riesgo de aterosclerosis. Rev Habanera Ciencias Médicas 2011; 10:441-7.

  95. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome- A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469-80.

  96. Soutelo J, Saban M, Faraj G, Fritz MC, González J, Barbero MR; et al. Relación entre circunferencia de cintura y factores de riesgo metabólicos en mujeres argentinas. Rev Arg Endocrinol Metab 2013;50:25-9.

  97. Han TS, Richmond P, Avenell A, Lean MEJ. Waist circumference reduction and cardiovascular benefits during weight loss in women. Int J Obes Relat Metab Dis 1997;21:127-34.

  98. Singh D. Female mate value at a glance: Relationship of waist-to-hip ratio to health, fecundity and attractiveness. Neuroendocrinol Lett 2002;23(Suppl 4): S81-S91.

  99. Singh D. Body shape and women’s attractiveness. Human Nature 1993;4: 297-321.

  100. Kościński K. Attractiveness of women’s body: Body mass index, waist– hip ratio, and their relative importance. Behav Ecol 2013;24:914-25.

  101. Taylor RW, Keil D, Gold EJ, Williams SM, Goulding A. Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: Evaluation using receiver operating characteristic curves. Am J Clin Nutr 1998;67:44-9.

  102. Chan DC, Watts GF, Barrett PHR, Burke V. Waist circumference, waist-tohip ratio and body mass index as predictors of adipose tissue compartments in men. QJM 2003;96: 441-7.

  103. Tehard B, Van Liere MJ, Nougué CC, Clavel-Chapelon F. Anthropometric measurements and body silhouette of women: Validity and perception. J Am Diet Assoc 2002;102:1779-84.

  104. Bulik CM, Wade TD, Heath AC, Martin NG, Stunkard AJ, Eaves LJ. Relating body mass index to figural stimuli: Population-based normative data for Caucasians. Int J Obes 2001;25: 1517-24.

  105. Vague J. The degree of masculine differentiation of obesities: A factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956;4:20-34.

  106. Huxley R, Mendis S, Zheleznyakov E, Reddy S, Chan J. Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk- A review of the literature. Eur J Clin Nutr 2010;64:16-23.

  107. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga P. Waist to hip ratio in middle-aged women. Associations with behavioral and psychosocial factors and with changes in cardiovascular risk factors. Arterioscl Thromb Vasc Biol 1991;11:1250-7.

  108. Gavilán VE, Goitia VE, Irala J, Luzuriaga GR, Rodríguez Coímbra MG, Costa S, Brandan JA, Nora C. Valoración del índice cintura-cadera y su correlación con el riesgo cardiovascular en un hospital de la ciudad de Corrientes. Revista CyT [Argentina] 2003; 45:151-4. Disponible en: http://www.revistacyt.unne.edu.ar/unnevi eja/Web/cyt/cyt/2002/03-Medicas/M- 057.pdf. Fecha de última visita: 12 de Noviembre del 2016.

  109. Castro ZLB, Romero SA, Muñoz AIG, Moreno AN. Índices aterogénicos y perfil cardiometabólico en adultos aparentemente sanos. Ciencia Salud [Colombia] 2014;3:39-44.

  110. De Oliveira M, Fagundes R, Moreira E, de Moraes Trindade E, de Carvalho T. Relación de indicadores antropométricos con factores de riesgo para enfermedad cardiovascular. Arq Bras Cardiol 2010; 94:462-9.

  111. Weltman A, Seip RL, Tran ZV. Practical assessment of body composition in adult obese males. Human Biology 1987;59:523-35.

  112. Weltman A, Levine S, Seip RL, Tran ZV. Accurate assessment of body composition in obese females. Am J Clin Nutr 1988;48:1179-83.

  113. Tran ZV, Weltman A. Predicting body composition of men from girth measurements. Human Biology 1988;60: 167-75.

  114. Tran ZV, Weltman A. Generalized equation for predicting body density of women from girth measurements. Med Sci Sports Exerc 1989;21:101-4.

  115. Wakabayashi I. Necessity of both waist circumference and waist-to-height ratio for better evaluation of central obesity. Metab Synd Relat Dis 2013;11: 189-94.

  116. Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-toheight ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev 2010; 23:247-69.

  117. Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr 2005;56:303-7.

  118. Ashwell M, Gunn P, Gibson S. Waist‐to‐height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: Systematic review and meta‐analysis. Obes Rev 2012;13:275-86.

  119. Bener A, Yousafzai MT, Darwish S, Al-Hamaq AO, Nasralla EA, Abdul- Ghani M. Obesity index that better predict metabolic syndrome: Body mass index, waist circumference, waist-hip ratio, or waist-height ratio. J Obes 2013: 2013. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articl es/PMC3755383/. Fecha de última visita: 13 de Noviembre del 2016.

  120. Savva SC, Tornaritis M, Savva ME, Kourides Y, Panagi A, Silikiotou N; et al. Waist circumference and waist-toheight ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes 2000;24:1453-60.

  121. Hernández Rodríguez J, Duchi Jimbo PN. Índice cintura/talla y su utilidad para detectar riesgo cardiovascular y metabólico. Rev Cubana Endocrinol 2015;26:66-76.

  122. Torresani ME, Oliva ML, Rossi ML, Echevarría C, Maffei L. Riesgo cardiovascular según el índice cintura/talla en mujeres adultas. Actualización en Nutrición [Argentina] 2014;15:3-9.

  123. Chávez AG, Lagunes JU, Saramago MDPDL, Chassin OA, Argueta SE, Hernández H. Comparación de índices antropométricos como predictores de riesgo cardiovascular y metabólico en población aparentemente sana. Rev Mex Cardiol 2011;22:59-67.

  124. Koch E, Romero T, Manríquez L, Taylor A, Román C, Paredes M; et al. Razón cintura-estatura: Un mejor predictor antropométrico de riesgo cardiovascular y mortalidad en adultos chilenos. Nomograma diagnóstico utilizado en el Proyecto San Francisco. Rev Chil Cardiol 2008;27:23-35.

  125. Franquelo Morales P, Serrano Martínez S, Moya Martínez P, Buendía Bermejo J, Sánchez López M, Solera Martínez M, Notario Pacheco B. Asociación entre distintas medidas de composición corporal y factores de riesgo cardiovascular en población adulta. Rev Clín Med Fam 2008;2: 149-55.

  126. Bellido D, de la Torre ML, Carreira J, de Luis D, Bellido V, Soto A; et al. Índices antropométricos estimadores de la distribución adiposa abdominal y capacidad discriminante para el síndrome metabólico en población española. Clínica Investigación Arteriosclerosis [España] 2013;25:105-9.

  127. Pérez MDCR, De León AC, Aguirre Jaime A, Coello SD, Díaz BB, González DA; et al. El cociente perímetro abdominal/estatura como índice antropométrico de riesgo cardiovascular y de diabetes. Medicina Clínica [Barcelona] 2010;134:386-91.

  128. Sánchez A, Muhn MA, Lovera M, Ceballos B, Bonneau G, Pedrozo W; et al. Índices antropométricos predicen riesgo cardiometabólico: Estudio de cohorte prospectivo en una población de empleados de hospitales públicos. Rev Arg Endocrinol Metab 2014;51:185-91.

  129. Gharakhanlou R, Farzad B, Agha- Alinejad H, Steffen LM, Bayati M. Anthropometric measures as predictors of cardiovascular disease risk factors in the urban population of Iran. Arquivos Brasil Cardiol 2012;98:126-35.

  130. Enzi G, Gasparo M, Biondetti PR, Fiore D, Semisa M, Zurlo F. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr 1986;44: 739-46.

  131. Wells JC. Sexual dimorphism of body composition. Best Pract Res Clin Endocrinol Metab 2007;21:415-30.

  132. Durnin JVGA, Rahaman MM. The assessment of the amount of fat in the human body from measurements of skinfold thickness. Brit J Nutrition 1967; 21:681-9.

  133. Durnin JVGA, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years. Brit J Nutr 1974;32: 77-97.

  134. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: The paradox between visceral and subcutaneous fat. Cur Diab Rev 2006;2:367-73.

  135. Després JP. Body fat distribution and risk of cardiovascular disease. Circulation 2012;126:1301-13.

  136. Ducimetiere P, Richard J, Cambien F. The pattern of subcutaneous fat distribution in middle-aged men and the risk of coronary heart disease: The Paris Prospective Study. Int J Obes 1986;10: 229-40.

  137. Mei Z, Grummer-Strawn LM, Wang J, Thornton JC, Freedman DS, Pierson R N; et al. Do skinfold measurements provide additional information to body mass index in the assessment of body fatness among children and adolescents? Pediatrics 2007:119(6 Suppl):e1306- e1313.

  138. Snijder MB, Van Dam RM, Visser M, Seidell JC. What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 2005; 35:83-92.

  139. Pinto EB, Indaburo PE, Muniz AC, Martinez YP, Gerent KM, Iwamoto H, Miziara AC. Superficial liposuction. Body contouring. Clin Plast Surg 1996; 23:529-48.

  140. Giese SY, Bulan EJ, Commons GW, Spear SL, Yanovski JA. Improvements in cardiovascular risk profile with largevolume liposuction: A pilot study. Plast Reconstruct Surg 2001;108:510-9.

  141. Gonzalez Ortiz M, Robles Cervantes JA, Cardenas Camarena L, Bustos Saldana R, Martinez Abundis E. The effects of surgically removing subcutaneous fat on the metabolic profile and insulin sensitivity in obese women after large-volume liposuction treatment. Horm Metab Res 2002;34:446-9.

  142. Robles Cervantes JA, Yánez Díaz S, Cárdenas Camarena L. Modification of insulin, glucose and cholesterol levels in nonobese women undergoing liposuction: Is liposuction metabolically safe? Ann Plast Surg 2004;52:64-7.

  143. Nielsen S, Guo ZK, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lipolysis in human obesity. J Clin Invest 2004;113:1582-8.

  144. Klein S. The case of visceral fat: Argument for the defense. J Clin Invest 2004;113:1530-2.

  145. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997;46:1579-85.

  146. Matarasso A, Kim RW, Kral JG. The impact of liposuction on body fat. Plast Reconstruct Surg 1998;102:1686-9.

  147. Escobar Vega H, Bezares Ramos I, Lugo Alonso J, Expósito Jalturin A, León Rodríguez Y. Cambios en las fracciones lipídicas séricas tras la liposucción. RCAN Rev Cubana Aliment Nutr 2014;24:249-59.

  148. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004;350:2549-57.

  149. Mohammed BS, Cohen S, Reeds D, Young VL, Klein S. Long‐term effects of large‐volume liposuction on metabolic risk factors for coronary heart disease. Obesity 2008;16:2648-51.

  150. Porter SA, Massaro JM, Hoffmann U, Vasan RS, O'Donnel CJ, Fox CS. Abdominal subcutaneous adipose tissue: A protective fat depot? Diabetes Care 2009;32:1068-75.

  151. Ruff C. Variation in human body size and shape. Annu Rev Anthropol 2002; 31:211-32.

  152. Ruff CB. Body size, body shape, and long bone strength in modern humans. J Human Evol 2000;38:269-90.

  153. Glauber HS, Vollmer WM, Nevitt M C, Ensrud KE, Orwoll ES. Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density. J Clin Endocrinol Metab 1995; 80:1118-23.

  154. Ruff CB. Body mass prediction from skeletal frame size in elite athletes. Am J Phys Anthropol 2000;113:507-17.

  155. Gurrici S, Hartriyanti Y, Hautvast JGAJ, Deurenberg P. Differences in the relationship between body fat and body mass index between two different Indonesian ethnic groups: The effect of body build. Eur J Clin Nutr 1999;53: 468-72.

  156. Deurenberg P, Deurenberg Yap M, Wang J, Lin FP, Schmidt G. The impact of body build on the relationship between body mass index and percent body fat. Int J Obes 1999;23:537-42.

  157. Snijder MB, Kuyf BE, Deurenberg P. Effect of body build on the validity of predicted body fat from body mass index and bioelectrical impedance. Ann Nutr Metab 1999;43:277-85.

  158. Hauspie RC, Vercauteren M, Susanne C. Secular changes in growth and maturation: An update. Acta Paediatrica 1997;86(S423):20-7.

  159. Frisancho AR. Anthropometric standards for the assessment of growth and nutritional status. University of Michigan Press. Ann Arbor: 1990.

  160. Henneberg M, Ulijaszek SJ. Body frame dimensions are related to obesity and fatness: lean trunk size, skinfolds, and body mass index. Am J Human Biol 2010;22:83-91.

  161. Mohebi R, Mohebi A, Sheikholeslami F, Azizi F, Hadaegh F. Wrist circumference as a novel predictor of hypertension and cardiovascular disease: Results of a decade follow up in a West Asian cohort. J Am Soc Hypertension 2014;8:800-7.

  162. Jahangiri Noudeh Y, Hadaegh F, Vatankhah N, Momenan AA, Saadat N, Khalili D, Azizi F. Wrist circumference as a novel predictor of diabetes and prediabetes: Results of cross-sectional and 8.8-year follow-up studies. J Clin Endocrinol Metab 2013;98:777-84.




2020     |     www.medigraphic.com